Male factors contribute to infertility in up to half of couples. Despite this, male evaluation is still frequently underemphasized or limited to a single semen analysis performed at a general laboratory. Our approach is more thorough, because what a standard semen analysis measures – and what it does not measure – can mean the difference between an effective treatment plan and months of misdirected effort.
The semen analysis remains the foundation of male fertility testing. We assess sperm concentration, motility, morphology, and volume to identify abnormalities that may affect conception. Importantly, we perform this analysis in our own andrology laboratory, where the clinical significance of subtle findings is not overlooked. A semen analysis done at a general lab, while better than nothing, may miss nuances that matter when treatment decisions depend on precise thresholds.
Standard semen parameters – concentration, motility, morphology – do not evaluate sperm DNA integrity. A man can have a normal-appearing semen analysis and still carry elevated levels of DNA fragmentation within the sperm cells themselves.
Elevated DNA fragmentation can impact fertilization, embryo development, implantation, and miscarriage risk. This test provides critical additional insight when semen parameters are borderline, when IVF has failed unexpectedly, or when pregnancy loss has occurred despite the transfer of apparently normal embryos.
If sperm DNA fragmentation is elevated, IVF with ICSI is recommended, since pregnancy rates are low with artificial intrauterine insemination in this setting. Knowing this upfront can save a couple from spending time and resources on IUI cycles that have a very low probability of success.
This is a novel assessment that goes beyond what even DNA fragmentation testing can tell us. The Sperm QT evaluates approximately 1,200 genes in sperm that are “functional genes” – genes directly involved in the sperm’s ability to find the egg, bind to the egg, and penetrate the egg for fertilization.
An abnormal Sperm QT result also implies a very low pregnancy rate unless the couple is treated with IVF and ICSI. This is a newer test, and not every clinic offers it. For couples with unexplained infertility or repeated IUI failure, it can provide a mechanistic explanation that standard testing simply cannot.
Healthy fallopian tubes and normal pelvic anatomy are essential for natural conception. Even in cases where IVF is being considered, understanding the anatomical landscape matters – a hydrosalpinx, for example, can actively reduce IVF success if left unaddressed.
The HSG is an X-ray study that evaluates tubal patency and the contour of the uterine cavity. It involves passing contrast dye through the cervix and observing whether it flows freely through the tubes. This test has been a mainstay of fertility evaluation for decades and remains a valuable first-line assessment of tubal status.
A saline-enhanced ultrasound provides a detailed evaluation of the uterine cavity that a standard ultrasound cannot match. By gently instilling sterile saline through a small catheter, we can identify polyps, fibroids, adhesions, or structural abnormalities that might otherwise be invisible on a routine scan. In some cases, saline infusion can also be used to demonstrate tubal patency in the office, avoiding the need for a separate HSG.
In selected patients – particularly those with suspected endometriosis, pelvic adhesions, or unexplained infertility that has not responded to less invasive treatment – minimally invasive laparoscopy may be recommended for both diagnosis and treatment. Laparoscopy requires general anesthesia and is performed in the operating room, allowing direct visual inspection of the pelvic anatomy.
What makes laparoscopy valuable in the right clinical context is that it is both diagnostic and therapeutic. Endometriosis, scar tissue, and other adhesive disease can be identified and treated during the same procedure, rather than requiring a second surgery. It is not appropriate for every patient, and we recommend it selectively when the clinical picture suggests findings that imaging alone cannot resolve.
Successful implantation depends on a receptive endometrium. Even when ovulation, sperm function, and tubal anatomy are all normal, an endometrial environment that is inflamed or otherwise compromised can prevent pregnancy.
Overexpression of BCL6 is associated with inflammation and endometriosis-related implantation dysfunction – sometimes in patients who have no classic symptoms of endometriosis at all. Identifying this marker before treatment begins may help guide medical or surgical intervention prior to proceeding with IVF, rather than discovering the problem only after a failed transfer.
This is an area where early detection changes decisions. A patient with elevated BCL6 may benefit from a period of medical suppression or surgical treatment before embryo transfer, rather than transferring a perfectly good embryo into an environment that is working against implantation.
Understanding egg quantity and reproductive timeline is essential for individualized planning. Ovarian reserve does not tell us about egg quality directly, but it tells us how a patient is likely to respond to stimulation, how urgently treatment should be pursued, and whether certain protocols need to be adjusted for safety or efficacy.
Our evaluation may include:
Together, these tests help guide stimulation protocols, predict response to fertility medications, and counsel patients regarding prognosis. They are also essential for identifying patients at risk of either poor response or ovarian hyperstimulation – both of which require protocol adjustments that are best made before stimulation begins.
Before conception, we assess overall health and optimize pregnancy readiness. This step is sometimes overlooked in the urgency to begin treatment, but it matters. Conditions identified at this stage – a thyroid imbalance, a missing immunity, an unrecognized Rh incompatibility – are far easier to address before pregnancy than during it.
Prenatal labs may include:
This ensures a safe and healthy start for both mother and baby, and it satisfies the laboratory requirements that must be completed before any assisted reproductive technology cycle can proceed.
Every human carries an estimated eight or more recessive disease mutations. Most of the time, this is of no consequence – a single copy of a recessive gene does not cause disease. But when both partners happen to carry the same recessive condition, each pregnancy carries a one-in-four chance of producing an affected child.
Expanded carrier screening allows us to evaluate both partners for hundreds of inherited recessive conditions. If both partners are found to carry the same condition, we can discuss reproductive options – including IVF with preimplantation genetic testing (PGT-M) – to reduce the risk of an affected pregnancy. This information is most useful before treatment begins, not after a pregnancy is already established.
Every patient’s journey is unique, and no evaluation template fits everyone. Our expanded infertility evaluation is designed to:
By taking a comprehensive and proactive approach, we aim to improve success rates while minimizing emotional and financial strain. The most expensive fertility treatment is the one that was never going to work because a correctable factor went undetected.
If you would like to learn more about our expanded evaluation process or schedule a consultation, our team is here to help you move forward with clarity and confidence.
Fertility Center & Applied Genetics of Florida
Sarasota: 5100 Station Way, Sarasota, FL 34233 | (941) 342-1568
Bonita Springs: 9420 Fountain Medical Court, Suite 100, Bonita Springs, FL 34135 | (239) 333-2229
Your Next Step:
Get your consultation time
by clicking the button below
or by calling 941-342-1568.
